Sign in
4/A

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-14-002057

Director gave up 2,927 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2013-12-31 Shares withheld for taxes −2,927 $4.34 $12,703 292,049 D
Loading xslF345X03/doc4a.xml…